Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma
Neurosurgical Review · 2024
DOI: 10.1007/s10143-024-02748-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurosurgical Review, 2024. Verfasst von Manal Nadeem und 3 weiteren Autor:innen. Beteiligte Einrichtung: Islamic International Medical College, Rawalpindi, MBBS, Pakistan. drmanalnadeem@gmail.com. Hauptthemen laut MEDLINE: Brain Neoplasms, Isocitrate Dehydrogenase, Astrocytoma, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
The study highlights that diffuse glioma, a prevalent type of brain tumor, affect approximately 100,000 individuals worldwide each year. IDH-mutant astrocytoma and oligodendrogliomas typically have a more favorable prognosis compared to IDH-wildtype glioblastomas. However, many IDH-mutant astrocytoma has the potential to progress to grade 4 glioblastomas, leading to a less favorable prognosis. In a recent investigation, Shumpei Onishi et al. examined the T2-FLAIR mismatch sign as a possible imaging biomarker for assessing CDKN2A status in non-enhancing IDH-mutant astrocytoma. The findings indicate that the T2-FLAIR mismatch sign is linked to CDKN2A-intact astrocytoma, providing a valuable tool for diagnostic and prognostic purposes. Additionally, the use of Indocyanine Green (ICG) for real-time visualization during neurosurgical procedures demonstrates potential, though it may have limitations in specificity. While these advancements offer promise in glioma management, there remains a critical need for larger, standardized studies to validate these findings and further improve treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Islamic International Medical College, Rawalpindi, MBBS, Pakistan. drmanalnadeem@gmail.com.
- Islamic International Medical College, Rawalpindi, MBBS, Pakistan.
Zitieren
APA
Nadeem, M., Shahzad, U. B., Tahir, N., & Areej, A. (2024). Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma. Neurosurgical Review. https://doi.org/10.1007/s10143-024-02748-8
Vancouver
Nadeem M, Shahzad UB, Tahir N, Areej A. Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma. Neurosurgical Review. 2024. doi:10.1007/s10143-024-02748-8
BibTeX
@article{Nadeem2024,
author = {Nadeem, Manal and Shahzad, Umer Bin and Tahir, Nawal and Areej, Ayesha},
title = {Enhancing glioma care with advanced imaging: T2-FLAIR mismatch as a predictive biomarker in IDH-mutant astrocytoma},
journal = {Neurosurgical Review},
year = {2024},
doi = {10.1007/s10143-024-02748-8}
}
EUVIMED